Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01382615|
Recruitment Status : Terminated (Unable to fill cohort)
First Posted : June 27, 2011
Last Update Posted : April 25, 2018
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||29 participants|
|Official Title:||Evaluation of Immune Parameters and Function in Multiple Myeloma Patients and Healthy Individuals' Blood and Marrow Samples|
|Study Start Date :||August 2010|
|Actual Primary Completion Date :||December 2014|
|Actual Study Completion Date :||December 2014|
Healthy volunteers who have agreed to have a bone marrow and/or blood harvest as part of a donation to a transplant recipient.
Patients with multiple myeloma
Patients undergoing routine blood draw and bone marrow aspirates as part of their ongoing follow-up care for myeloma at the Norris Cotton Cancer Center of DHMC.
- Cancer cell response to molecular testing of killing cell parts. [ Time Frame: 2 Years ]This myeloma specific killing may help identify mechanisms, in vitro, of killing myeloma cells for the future use in clinical trials.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01382615
|United States, New Hampshire|
|Dartmouth-Hitchcock Medical Center|
|Lebanon, New Hampshire, United States, 03756|
|Principal Investigator:||Kenneth Meehan, MD||Dartmouth-Hitchcock Medical Center|